APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 6mg capsule blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

rivastigmine hydrogen tartrate, Quantity: 9.6 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN（国際名）:

rivastigmine hydrogen tartrate

医薬品形態:

Capsule

構図:

Excipient Ingredients: maize starch; microcrystalline cellulose; Gelatin; iron oxide red; stearic acid; titanium dioxide; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

投与経路:

Oral

パッケージ内のユニット:

112, 28, 56, 14

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

製品概要:

Visual Identification: Hard gelatine calsule with orange, opaque body and red opaque cap. Imprinted "APO R6" in black ink, white to off white fill.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Registered

承認日:

2010-07-27